0001415889-24-015543.txt : 20240605 0001415889-24-015543.hdr.sgml : 20240605 20240605160545 ACCESSION NUMBER: 0001415889-24-015543 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240603 FILED AS OF DATE: 20240605 DATE AS OF CHANGE: 20240605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wright Richard M. CENTRAL INDEX KEY: 0001646423 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 241022006 MAIL ADDRESS: STREET 1: C/O CELLDEX THERAPEUTICS, INC. STREET 2: 53 FRONTAGE ROAD, SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 form4-06052024_080641.xml X0508 4 2024-06-03 0000744218 Celldex Therapeutics, Inc. CLDX 0001646423 Wright Richard M. C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220 HAMPTON NJ 08827 false true false false SR. VP & CCO 0 Common Stock 2024-06-03 4 M 0 20625 2.78 A 20833 D Common Stock 2024-06-03 4 M 0 28469 28 A 49302 D Common Stock 2024-06-03 4 M 0 18375 22.48 A 67677 D Common Stock 2024-06-03 4 S 0 27580 33.5264 D 40097 D Common Stock 2024-06-03 4 S 0 19264 33.9854 D 20833 D Incentive Stock Option (right to buy) 2.78 2024-06-03 4 M 0 20625 0 D 2029-06-19 Common Stock 20625 0 D Incentive Stock Option (right to buy) 28 2024-06-03 4 M 0 28469 0 D 2031-06-17 Common Stock 28469 13531 D Incentive Stock Option (right to buy) 22.48 2024-06-03 4 M 0 18375 0 D 2032-06-16 Common Stock 18375 23625 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.81 to $33.81 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.815 to $34.20 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. As of June 19, 2023, the option is fully vested. 25% vested on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. 25% vested on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. /s/ Sam Martin, attorney-in-fact for Richard M. Wright 2024-06-05